The Latest Breaking News from TGA

US-based supplement store iHerb has suspended sales of melatonin to Australia following a spike in child overdoses in Western Australia.

Medicinal cannabis use has increased rapidly in recent years in Australia. Since access pathways were expanded in 2016, more than 700,000 prescription approvals have been issued.

A small Australian trial that used psychedelic-assisted therapy to improve the mental health and wellbeing of terminally ill patients is in the news today.

Spinal cord stimulators are electrical devices that are surgically implanted in the body to treat long-term pain. They have a battery pack and leads that deliver electrical impulses directly to the spinal cord. The devices are thought to work by providing electrical impulses that interfere with how the brain senses…

A pharmacology expert says the threat of cancer from sun exposure is far more serious than any potential negative effects from sunscreens

Last week, the Therapeutic Goods Administration (TGA) released its safety review of seven active ingredients commonly used in sunscreens.

In 2024 alone, Australia’s medicines regulator, the Therapeutic Goods Administration (TGA), authorised at least 979,000 prescription applications for medicinal cannabis through its specialised access pathways.

With Australia having one of the highest rates of skin cancer in the world, the consumer advocate group’s report left many worried and wondering about the brands they use

The Australian regulator admits it may have underestimated the extent of the side effects from vitamin B6 supplements